SEC Info - Valera Pharmaceuticals Inc - ‘425’ on 12/12/06 re: Endo Pharmaceuticals Solutions Inc.

SEC Info℠

Home

Help

Please Sign In

Valera Pharmaceuticals Inc – ‘425’ on 12/12/06 re: Endo Pharmaceuticals Solutions Inc.

On: Tuesday, 12/12/06, at 5:17pm ET · Accession #: 1193125-6-251710 · File #: 0-18728

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/12/06  Valera Pharmaceuticals Inc        425                    6:2.4M Endo Pharmas Solutions Inc.       RR Donnelley/FA

Business-Combination Transaction Communication — Rule 425
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 425         Form 8-K                                            HTML     40K 
 2: EX-2.1      Agreement and Plan of Merger                        HTML    429K 
 3: EX-99.1     Voting Agreement                                    HTML     55K 
 4: EX-99.2     Voting Agreement                                    HTML     64K 
 5: EX-99.3     Presentation                                        HTML    145K 
 6: EX-99.4     Fact Sheet                                          HTML     18K

Filing Submission 0001193125-06-251710 – SGML Text

Original SGML Text submitted by:	Donnelley Financial Solutions/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Valera Pharmaceuticals Inc – ‘425’ on 12/12/06 re: Endo Pharmaceuticals Solutions Inc.

On: Tuesday, 12/12/06, at 5:17pm ET · Accession #: 1193125-6-251710 · File #: 0-18728

Previous ‘425’: ‘425’ on 12/12/06 · Next: ‘425’ on 12/13/06 · Latest: ‘425’ on 4/12/07

Business-Combination Transaction Communication — Rule 425Filing Table of Contents

To view the SGML, please refresh this page.

Business-Combination Transaction Communication — Rule 425
Filing Table of Contents

To view the SGML, please refresh
this page.